SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042657
Filing Date
2021-08-09
Accepted
2021-08-09 16:17:45
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-10q_20210630.htm   iXBRL 10-Q 2547300
2 EX-31.1 sndx-ex311_8.htm EX-31.1 10276
3 EX-31.2 sndx-ex312_7.htm EX-31.2 10726
4 EX-32.1 sndx-ex321_9.htm EX-32.1 11871
  Complete submission text file 0001564590-21-042657.txt   9309996

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210630.xsd EX-101.SCH 56129
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20210630_cal.xml EX-101.CAL 48829
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20210630_def.xml EX-101.DEF 176776
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210630_lab.xml EX-101.LAB 389796
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210630_pre.xml EX-101.PRE 288739
10 EXTRACTED XBRL INSTANCE DOCUMENT sndx-10q_20210630_htm.xml XML 2101624
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 211156728
SIC: 2834 Pharmaceutical Preparations